CD30 Recombinant Rabbit mAb (SDT-216-2),Starter_specification/price/image

Product Detail
Company Profile

Product Specification

Host	Rabbit
Antigen	CD30
Synonyms	Ki-1, KI-30 Ber-H2, Tumor necrosis factor receptor superfamily member 8, TNFRSF8, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30
Immunogen	Synthetic Peptide
Location	Cytoplasm, Cell membrane
Accession	P28908
Clone Number	SDT-216-2
Antibody Type	Recombinant mAb
Application	IHC-P, ICC, ICFCM
Reactivity	Hu, Ms
Purification	Protein A
Concentration	0.25 mg/ml
Physical Appearance	Liquid
Storage Buffer	PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
Stability & Storage	12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution

application	dilution	species
IHC-P	1:500
ICC	1:250
ICFCM	1:25

Background

CD30 is a transmembrane protein from the tumour necrosis factor receptor superfamily. It is expressed on a small subset of activated T and B lymphocytes, and various lymphoid neoplasms. CD30 is a particularly treatment target because its levels are high in tumours but low in healthy tissues. Several therapeutic strategies targeting CD30 have been developed, including monoclonal antibodies, conjugated antibodies (combination of brentuximab vedotin with chemotherapy or immunotherapy), bispecific antibodies and cell and gene therapies, such as anti-CD30 CAR-T cells in particular [PMID: 37170397].

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.